Natura Sells Avon International to Regent in Strategic Pivot

Brazilian cosmetics giant Natura has officially announced the sale of its Avon International unit to Regent, a prominent holding firm. This strategic move brings an end to a prolonged period of speculation and uncertainty that began last year when Natura first indicated it was exploring alternatives for the business arm. The news was met with immediate approval from investors, as Sao Paulo-traded shares in Natura surged by over 13% following the announcement, signaling confidence in the company's refined strategic direction.

This divestiture is a crucial component of Natura's broader strategy aimed at simplifying its complex corporate structure, streamlining business operations, and sharpening its focus on the burgeoning Latin American market. The company has grappled with profitability challenges in recent years, making the shedding of less profitable assets a key priority. Avon International, in particular, had been consistently posting lower margins compared to Natura's robust Latin American operations, necessitating a re-evaluation of its place within the group.

The sale of Avon International is not an isolated incident but rather the latest in a series of strategic divestitures undertaken by Natura. The company previously divested its stake in the luxury skincare brand Aesop and, before that, sold The Body Shop. Just earlier this week, Natura also finalized a deal to sell Avon's businesses in several Central American countries to Grupo PDC, further underscoring its commitment to a more focused and agile operational model.

The transaction with an acquisition vehicle affiliated with Regent encompasses Avon's extensive operations across Europe, Africa, and Asia, as outlined in Natura's official statement. It is important to note, however, that the deal does not include Avon's Russian business, which remains classified as "held for sale" awaiting a separate resolution. Crucially, Avon's highly valued operations within Latin America are also excluded, as they form the bedrock of Natura's core strategic priorities. Furthermore, Avon's U.S. business, which was never part of Natura's portfolio, is entirely separate from this agreement.

Financially, Natura is set to receive a nominal consideration of 1.00 pound (approximately $1.36) at the closing of the deal. Beyond this initial amount, the agreement includes provisions for contingent payments, which could amount to a maximum of 60 million pounds. These future payments are tied to Avon International's performance, specifically its future results and certain liquidity events. The journey to this sale began last year when Natura publicly stated it was "weighing alternatives" for the unit, leading to its reclassification as an "asset for sale" in August, setting the stage for Thursday's announcement.

Analysts have largely welcomed the move, with experts from Santander noting the positive implications for Natura. They highlighted that the sale significantly reduces concerns regarding potential future cash injection requirements to sustain Avon International's operations, a unit they pointedly described as "cash-burning." This strategic divestment is expected to bolster Natura's financial health, allowing it to dedicate resources more effectively to its most profitable ventures and strengthen its position in the strategically vital Latin American beauty market.